Literature DB >> 2234783

Cytotoxic activity of lysophosphatidylcholine analogues on human lymphoma Raji cells.

E A Fleer1, D J Kim, G A Nagel, H Eibl, C Unger.   

Abstract

The cytotoxic activity of 21 lysophosphocholine analogues was tested on human lymphoma Raji cells. Structure-activity investigations revealed a more than 50-fold difference in the cytotoxicity between the different compounds. Whereas acyllysophosphocholines showed only borderline effects, the most pronounced toxic activity was observed with compounds which have an etherbond in the sn-1 position and a hydrogen, a methoxy or a methoxymethylgroup in position sn-2. Elongation of the phosphorous-nitrogen distance in the choline group markedly reduced the cytotoxicity of the compounds. From the results obtained it was concluded that a long chain fatty alcohol adjacent to a phosphocholine headgroup represents the minimal requirement for antineoplastic activity. Thus, a new group of antineoplastic compounds, the alkylphosphocholines, was developed in our laboratory, with in vitro cytotoxic activities just as effective as the most toxic alkyllysophosphocholines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2234783     DOI: 10.1159/000216779

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  8 in total

Review 1.  Glycosidated phospholipids: uncoupling of signalling pathways at the plasma membrane.

Authors:  Kerstin Danker; Werner Reutter; Geo Semini
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

2.  [Spectrographic studies on the radioresistance of Miltex and miltefosine].

Authors:  G Bollmann; H Paukisch; E Bothe; W Strate; G Gademann
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

3.  Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations.

Authors:  J Kötting; M R Berger; C Unger; H Eibl
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Comparative toxicity of oxidatively modified low-density lipoprotein and lysophosphatidylcholine in cultured vascular endothelial cells.

Authors:  M Naito; K Yamada; T Hayashi; K Asai; N Yoshimine; A Iguchi
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

5.  Distribution of hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine in rat tissues during steady-state treatment.

Authors:  N Marschner; J Kötting; H Eibl; C Unger
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  Pharmacokinetic behavior and antineoplastic activity of liposomal hexadecylphosphocholine.

Authors:  P Kaufmann-Kolle; J Drevs; M R Berger; J Kötting; N Marschner; C Unger; H Eibl
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

7.  Effects of hexadecylphosphocholine on fatty acid metabolism: relation to cytotoxicity.

Authors:  M Goppelt-Struebe; I Winter
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

8.  Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipids.

Authors:  M Lohmeyer; P Workman
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.